A 28-year-old woman from West Bengal with confirmed P. falciparum malaria (uncomplicated, no severe features) presents with fever and malaise. She is fully conscious, has no neurologic signs, and hemoglobin is 9.5 g/dL. What is the drug of choice for treatment of this acute attack?

Explanation

## Treatment of Uncomplicated P. falciparum Malaria **Key Point:** Artemisinin-based combination therapy (ACT) is the WHO-recommended and Indian national guideline first-line treatment for all P. falciparum malaria, including uncomplicated cases. Chloroquine is no longer used due to widespread resistance. ### Why ACT is Superior | Feature | Chloroquine | ACT | |---------|-------------|-----| | **Efficacy** | ~30% failure rate in P. falciparum | >95% cure rate | | **Resistance** | Widespread (>50% in India) | Minimal (< 1%) | | **Parasite clearance** | 72+ hours | 24–48 hours | | **Gametocide activity** | Weak | Strong (prevents transmission) | | **Current status** | Obsolete for P. falciparum | First-line, WHO-endorsed | **High-Yield:** ACT combinations approved in India include: - Artemether + lumefantrine (Coartem) - Artesunate + amodiaquine - Dihydroartemisinin + piperaquine - Artesunate + mefloquine ### Mechanism of ACT 1. **Artemisinin derivative** (fast-acting): Kills parasites within 24 hours; reduces gametocyte production 2. **Partner drug** (slow-acting): Provides sustained parasite suppression and prevents recrudescence **Clinical Pearl:** The combination strategy exploits the rapid action of artemisinin to clear parasitemia quickly and the sustained action of the partner drug to prevent relapse. This synergy is why monotherapy with either component alone is inferior. **Mnemonic:** **ACT = Artemisinin + Combination Therapy** - **A** = Artemisinin (rapid kill) - **C** = Combination (prevents resistance) - **T** = Therapy (gold standard) ### Treatment Duration - **Uncomplicated P. falciparum**: 3-day ACT course - **Dose**: Weight-based, as per product formulation - **Follow-up**: Blood smear on day 7 to confirm parasite clearance **Warning:** Do NOT use chloroquine for P. falciparum — resistance is >50% in most Indian endemic zones. Monotherapy with artemisinin alone risks resistance development; always use combination therapy.